ATE417629T1 - Hochvisköse embolisierende mittel - Google Patents

Hochvisköse embolisierende mittel

Info

Publication number
ATE417629T1
ATE417629T1 AT00936075T AT00936075T ATE417629T1 AT E417629 T1 ATE417629 T1 AT E417629T1 AT 00936075 T AT00936075 T AT 00936075T AT 00936075 T AT00936075 T AT 00936075T AT E417629 T1 ATE417629 T1 AT E417629T1
Authority
AT
Austria
Prior art keywords
high viscosity
embolizing agents
viscosity embolizing
agents
discolsed
Prior art date
Application number
AT00936075T
Other languages
English (en)
Inventor
Thomas Whalen
Chinh Tran
Noah Roth
Richard Greff
Original Assignee
Micro Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Therapeutics Inc filed Critical Micro Therapeutics Inc
Application granted granted Critical
Publication of ATE417629T1 publication Critical patent/ATE417629T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Liquid Crystal Substances (AREA)
AT00936075T 1999-05-21 2000-05-19 Hochvisköse embolisierende mittel ATE417629T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13528899P 1999-05-21 1999-05-21

Publications (1)

Publication Number Publication Date
ATE417629T1 true ATE417629T1 (de) 2009-01-15

Family

ID=22467408

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936075T ATE417629T1 (de) 1999-05-21 2000-05-19 Hochvisköse embolisierende mittel

Country Status (9)

Country Link
US (5) US6531111B1 (de)
EP (2) EP1987847A1 (de)
JP (1) JP5148030B2 (de)
AT (1) ATE417629T1 (de)
AU (1) AU5144200A (de)
CA (1) CA2371321C (de)
DE (1) DE60041138D1 (de)
ES (1) ES2319725T3 (de)
WO (1) WO2000071170A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0928195B1 (de) * 1996-05-31 2003-01-02 Micro Therapeutics, Inc. Zusammensetzungen zur verwendung bei der embolisierung von blutgefässen
US6051607A (en) * 1998-07-02 2000-04-18 Micro Therapeutics, Inc. Vascular embolizing compositions comprising ethyl lactate and methods for their use
CA2319447C (en) * 1998-12-01 2010-01-26 Washington University Embolization device
US6531111B1 (en) * 1999-05-21 2003-03-11 Micro Therapeutics, Inc. High viscosity embolizing compositions
WO2001003666A2 (en) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Liquid based vaso-occlusive compositions
EP1392182A1 (de) * 2001-05-04 2004-03-03 Concentric Medical Hydrogel-vorrichtung zum verschluss eines blutgefässes
US20030004533A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Bioactive polymer vaso-occlusive device
WO2002089676A2 (en) * 2001-05-04 2002-11-14 Concentric Medical Hydrogel filament vaso-occlusive device
EP1438097B1 (de) 2001-09-04 2018-09-05 Covidien LP Okklusionskatheter mit nachgiebigem ballon zur verwendung in komplexen gefässen
US20030093111A1 (en) * 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
EP1465668A2 (de) 2002-01-14 2004-10-13 Micro Therapeutics, Inc. Verfahren zur embolisierung aneurysmatischer stellen mit einer hochviskosen embolisierungszusammensetzung
FR2839450B1 (fr) * 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales
US7338511B2 (en) * 2002-05-24 2008-03-04 Boston Scientific-Scimed, Inc. Solid embolic material with variable expansion
AU2003277361A1 (en) * 2002-10-10 2004-05-04 Micro Therapeutics, Inc. Wire braid-reinforced microcatheter
WO2004035022A2 (en) * 2002-10-15 2004-04-29 Microtherapeutics, Inc. Prepolymeric materials for site specific delivery to the body
EP1599258B1 (de) * 2003-02-26 2008-08-06 Micro Therapeutics, Inc. Emboliezusammensetzungen enthaltend pyrogenes silicium
US20050025707A1 (en) * 2003-02-27 2005-02-03 Patterson William R. Fumed silica embolic compositions
ATE429940T1 (de) * 2003-03-07 2009-05-15 Micro Therapeutics Inc Zusammensetzungen enthaltend hohe konzentration von kontrastmittel zur embolisierung von blutgefassen
US7396540B2 (en) * 2003-04-25 2008-07-08 Medtronic Vascular, Inc. In situ blood vessel and aneurysm treatment
RU2373958C2 (ru) 2003-09-25 2009-11-27 Рутгерс, Дзе Стейт Юниверсити Полимерные по существу рентгеноконтрастные продукты для эмболотерапии
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
JP5014571B2 (ja) * 2003-12-17 2012-08-29 コーディス・ニューロバスキュラー・インコーポレイテッド 活性化可能で生体活性な移植可能の医療装置およびその使用方法
US20050255230A1 (en) * 2004-05-17 2005-11-17 Clerc Claude O Method of manufacturing a covered stent
US20100087546A1 (en) * 2005-04-20 2010-04-08 Biogenic Innovations, Llc Use of dimethyl sulfone (msm) to reduce homocysteine levels
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US8480797B2 (en) * 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US9307995B2 (en) * 2006-06-15 2016-04-12 Cook Medical Technologies Llc Methods, systems and devices for the delivery of endoluminal prostheses
JP2010500917A (ja) 2006-06-15 2010-01-14 マイクロベンション， インコーポレイテッド 膨張性ポリマーで構成される塞栓形成デバイス
US8114630B2 (en) 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
EP2187983B1 (de) * 2007-09-12 2014-04-16 Cook Incorporated Verbessertes umgestaltbares material für den verschluss von körpergefässen
AU2008345590B2 (en) 2007-12-21 2014-10-30 Microvention, Inc. Hydrogel filaments for biomedical uses
US9468739B2 (en) 2008-08-19 2016-10-18 Covidien Lp Detachable tip microcatheter
US9005154B2 (en) 2008-09-26 2015-04-14 Covidien Lp Valved hemodialysis catheter
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
BRPI1014645B1 (pt) 2009-04-30 2020-07-07 Technip France método e sistema para compartilhar linhas de amarração
CN102791183B (zh) 2009-10-26 2015-07-08 微排放器公司 由可膨胀的聚合物构成的栓塞装置
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
JP5713732B2 (ja) 2011-03-08 2015-05-07 日本コヴィディエン株式会社 弁付きカテーテル
CN102139128A (zh) * 2011-03-22 2011-08-03 杭州艾力康医药科技有限公司 可显影聚乙烯醇微球/颗粒栓塞剂及其制备工艺
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
US8936784B2 (en) 2011-10-17 2015-01-20 Poly-Med, Inc. Absorbable in situ gel-forming system, method of making and use thereof
CA2852386C (en) * 2011-10-17 2019-05-21 Poly-Med, Inc. Absorbable in situ gel-forming system, method of making and use thereof
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
AU2013274199B2 (en) * 2012-06-14 2016-08-11 Microvention, Inc. Polymeric treatment compositions
US10124087B2 (en) 2012-06-19 2018-11-13 Covidien Lp Detachable coupling for catheter
US10143822B2 (en) 2012-07-05 2018-12-04 Covidien Lp Valved tip catheters
WO2014062696A1 (en) * 2012-10-15 2014-04-24 Microvention, Inc. Polymeric treatment compositions
US10674966B2 (en) 2012-12-11 2020-06-09 Covidien Lp Systems for diagnosing and/or treating medical conditions
WO2015058169A2 (en) * 2013-10-17 2015-04-23 Lisner Elaine Compositions and methods relating to an occlusive polymer hydrogel
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
EP3137124B1 (de) 2014-04-29 2019-01-09 Microvention, Inc. Polymere mit wirkstoffen
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
US20170136144A1 (en) 2015-11-12 2017-05-18 John C. Herr Compositions and methods for vas-occlusive contraception
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
EP4400166A3 (de) 2017-01-05 2025-01-22 Contraline, Inc. Verfahren zum implantieren und umkehren von stimulierend wirkenden implantaten
US12383421B2 (en) 2017-01-05 2025-08-12 Contraline, Inc. Contraceptive devices
JP7362598B2 (ja) 2017-10-09 2023-10-17 マイクロベンション インコーポレイテッド 放射性液体塞栓物質
FR3083090B1 (fr) * 2018-07-02 2020-06-05 Rene Chapot Agent d’embolisation
JP7582939B2 (ja) 2018-11-13 2024-11-13 コントラライン，インコーポレイテッド 生体材料を送達するためのシステムおよび方法
IL289116B2 (en) * 2019-06-19 2024-12-01 Becton Dickinson Co Biodegradable drug-eluting embolic particles for delivery of therapeutic agents

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527224A (en) 1967-09-05 1970-09-08 American Cyanamid Co Method of surgically bonding tissue together
US3591676A (en) 1968-11-01 1971-07-06 Eastman Kodak Co Surgical adhesive compositions
US4079124A (en) 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
WO1985000969A1 (en) 1983-08-31 1985-03-14 S.K.Y. Polymers Ltd. Injectable physiologically acceptable polymeric compositions
US4631188A (en) 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
ATE130517T1 (de) 1990-08-08 1995-12-15 Takeda Chemical Industries Ltd Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff.
US5292782A (en) * 1991-02-20 1994-03-08 Novamont S.P.A. Biodegradable polymeric compositions based on starch and thermoplastic polymers
JP3040551B2 (ja) 1991-09-05 2000-05-15 株式会社カネカメディックス 人工塞栓形成用高分子溶液
JP3203382B2 (ja) 1992-03-13 2001-08-27 国立循環器病センター総長 人工塞栓形成用高分子溶液
JP2736339B2 (ja) 1992-09-30 1998-04-02 株式会社日本感光色素研究所 動脈瘤の液体塞栓材料
US5443454A (en) 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
ES2232711T3 (es) * 1995-07-27 2005-06-01 Micro Therapeutics, Inc. Composiciones de embolizacion.
US5580568A (en) * 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5667767A (en) 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US5695480A (en) 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6155668A (en) 1998-02-13 2000-12-05 Seiko Epson Corporation Printer, method of printing, and computer program product to actualize the printer
US6051607A (en) * 1998-07-02 2000-04-18 Micro Therapeutics, Inc. Vascular embolizing compositions comprising ethyl lactate and methods for their use
US6531111B1 (en) * 1999-05-21 2003-03-11 Micro Therapeutics, Inc. High viscosity embolizing compositions
WO2000071196A1 (en) * 1999-05-21 2000-11-30 Micro Therapeutics, Inc. Interface needle and method for creating a blunt interface between delivered liquids
WO2000071064A1 (en) * 1999-05-21 2000-11-30 Micro Therapeutics, Inc. Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity
WO2004035022A2 (en) * 2002-10-15 2004-04-29 Microtherapeutics, Inc. Prepolymeric materials for site specific delivery to the body

Also Published As

Publication number Publication date
US20030086874A1 (en) 2003-05-08
CA2371321C (en) 2008-12-23
CA2371321A1 (en) 2000-11-30
WO2000071170A9 (en) 2002-04-18
EP1206287A4 (de) 2004-06-30
US20030059372A1 (en) 2003-03-27
EP1206287A1 (de) 2002-05-22
WO2000071170A1 (en) 2000-11-30
US20020090339A1 (en) 2002-07-11
DE60041138D1 (de) 2009-01-29
US6531111B1 (en) 2003-03-11
US6962689B2 (en) 2005-11-08
EP1206287B1 (de) 2008-12-17
JP2003500114A (ja) 2003-01-07
US20030099597A1 (en) 2003-05-29
EP1987847A1 (de) 2008-11-05
JP5148030B2 (ja) 2013-02-20
ES2319725T3 (es) 2009-05-12
AU5144200A (en) 2000-12-12
US7507394B2 (en) 2009-03-24

Similar Documents

Publication Publication Date Title
ATE417629T1 (de) Hochvisköse embolisierende mittel
EP0847240A4 (de) Embolisierende zusammensetzungen
ATE316786T1 (de) Behandlung von mukositis
GB0213612D0 (en) Organic compounds
ATE504308T1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
TR200101539T2 (tr) Serum glukoz ve trigliserid seviyelerini düşürme yöntemleri.
DE10085007T1 (de) Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes
ATE285798T1 (de) Radioaktive embolisierende zusammensetzungen
WO2005063745A8 (en) Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
IL183953A0 (en) Method of reducing oxidant induced damage of a food product, a pharmaceutical, or stored blood
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
AU5977401A (en) Delivery devices for treatment of vascular disease
PT842934E (pt) Agonistas de 5-ht1f
PH31265A (en) Aqueous solution inclusion complexes of benzo-thiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof.
ATE345775T1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
IS5591A (is) Grunnmassaprótínsamsetningar til sáragræðslu
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
GB0211247D0 (en) Compositions and methods for treating or preventing convulsions or seizures
DE60234354D1 (de) Piperazinon-verbindungen als antitumorale und krebsbekämpfende mittel
ITBO990309A0 (it) Macchina per la realizzazione di sacchetti - filtro di prodotti da inf usione .
EP1545479A4 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
WO2000071716A3 (en) Vascular endothelial growth factor dimers
ID25478A (id) Agonis 5-ht1f

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206287

Country of ref document: EP